The transaction, subject to regulatory approval, is expected to close later this year, a Cardinal spokesperson said.

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Integrated Oncology ...

Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & ...

CG Oncology (NASDAQ:CGON) is up ~7% in Monday trading as the company's candidate for a type of bladder cancer is seen as ...

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

The European Society for Medical Oncology (ESMO) is calling on all actors of the oncology community to commit to improving the well-being of the cancer workforce and join in 11 actions outlined in a ...

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, today announces that the company will present updated data from the ...

Bispecific antibodies and anti-TIGIT therapies both appear to be writing comeback stories as cancer experts head to Barcelona for the 2024 European Society for Medical Oncology Congress. Radioligand ...

The new executive director of New York Oncology Hematology is Allyson Letendre Petrone, the physician group announced Monday.